SCHEMBL6356479

SCHEMBL6356479

NC(O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.58
SLC15A1 P46059 1/20 0.55
SLC6A2 P23975 2/20 0.54
TAAR1 Q96RJ0 2/20 0.54
MAOA P21397 1/20 0.54
SLC6A4 P31645 1/20 0.54
SLC6A3 Q01959 1/20 0.54
SIGMAR1 Q99720 1/20 0.54
CYP2A6 P11509 1/20 0.54
ADORA2A P29274 1/20 0.54
ADORA1 P30542 1/20 0.54
ALPI P09923 1/20 0.54
PKM P14618 1/20 0.54
PTGS1 P23219 1/20 0.54
XIAP P98170 1/20 0.54
SLC7A5 Q01650 1/20 0.54
CSNK1E P49674 1/20 0.53
LAP3 P28838 3/20 0.50
ANPEP P15144 2/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14026104 1.00 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL14544346 1.00 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL14417418 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL6445044 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL6931887 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL6929688 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL6446370 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL7190709 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL22431194 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA
SCHEMBL9740410 0.86 EPHX1 (0.58) EPHX1SLC15A1SLC6A2TAAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187274-A1 One pot synthesis of 2-oxazolidinone derivatives PATEL RAJNIKANT (GB) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187274-A1 One pot synthesis of 2-oxazolidinone derivatives AZI2, INTS6, NISCH EPHX1 4435/4885SLC15A1 2358/4885SLC6A2 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.